Case report
Invasive aspergillosis of the lung and pericardium in a nonimmunocompromised 33 year old man

https://doi.org/10.1016/0002-9343(81)90396-XGet rights and content

Abstract

In a 33 year old man with no discernible immunologic defect, invasive aspergillosis developed in both the pericardium and lung with marked granulomatous reaction. The patient received 2 g of intravenous amphotericin B over eight weeks, with partial regression of the pulmonary infiltrate and disappearance of symptoms. However, five months later, he returned with marked progression of his disease. Evaluation of host defense, including granulocyte and lymphocyte function, was normal. The patient was given an additional 3 g of amphotericin B over nine weeks with marked improvement in symptoms and chest roentgenogram. At six-month follow-up, he was asymptomatic with a stable radiographic appearance. A recurrence in symptoms and the pulmonary infiltrate was noted two months later. He was treated with an additional course of amphotericin and currently is receiving ketoconazole in hopes of suppressing the infection. We could find no immune impairment to explain the severe pulmonary and pericardial disease due to Aspergillus flavus in this young man.

References (33)

  • GM Lazrus et al.

    Agents responsible for infection in chronic granulomatous disease of childhood

    J Pediatr

    (1975)
  • A Toigo

    Pulmonary aspergillosis

    Am Rev Respir Dis

    (1960)
  • SR Zellner et al.

    Aspergillosis, an unusual presentation

    Am Rev Respir Dis

    (1969)
  • LV Schneider

    Primary aspergillosis of the lung

    Am Rev TB

    (1930)
  • IM Librach

    Primary pulmonary aspergillosis: report of a fatal case

    Antibiot Med

    (1957)
  • SD Codish et al.

    Combined amphotericin B flucytosine therapy in aspergillus pneumonia

    JAMA

    (1979)
  • Cited by (46)

    • Myocarditis and Pericarditis

      2014, Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
    • Aspergillosis pathogenesis, clinical manifestations, and therapy

      2002, Infectious Disease Clinics of North America
    • Invasive aspergillosis in systemic lupus erythematosus

      1995, Seminars in Arthritis and Rheumatism
    View all citing articles on Scopus
    1

    From the Department of Medicine, Infectious Diseases and Pulmonary Divisions, University of Virginia School of Medicine, Charlottesville, Virginia.

    Present address: Department of Physiology, University of Pennsylvania Medical School, Philadelphia, Pennsylvania 19146.

    View full text